Nasal administration
US11554229B2 · kind B2 · utility
0Cited by
61References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 25, 2014 |
| Grant date | Jan 17, 2023 |
| Priority date | — |
| Expiry date | May 24, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2205/3334
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A method of delivering a substance, such as one or more of a triptan, a nasal steroid or carbon dioxide gas, to the nasal cavity of a subject, in particular for the treatment of headaches, for example, migraine, or rhinosinusitis, for example, chronic rhinosinusitis, optionally with polyps, the method comprising the steps of fitting a nosepiece to one nostril of the subject, delivering the substance through the nosepiece to the posterior region of the nasal cavity of the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.